Does Peritoneal Protein Transport Increase with Peritoneal Dialysis Therapy Duration and Lead to Extracellular Water Overload in Peritoneal Dialysis Patients? by Goodlad, C & Davenport, A
1 
 
Does peritoneal protein transport increase with peritoneal dialysis therapy duration and 
lead to extracellular water overload in peritoneal dialysis patients? 
 
Cate Goodlad MRCP, Andrew Davenport FRCP 
UCL Centre for Nephrology, Royal Free Hospital, University College London Medical 
School, London NW3 2PF, UK 
 
Cate Goodlad   c.goodlad@nhs.net   
Andrew Davenport  andrewdavenport@nhs.uk 
 
Address for correspondence 
A Davenport, UCL Centre for Nephrology, Royal Free Hospital, University College 
London Medical School, Rowland Hill Street, London NW3 2PF, UK 





Body  2993 
References 32 
Figures 4 
Tables  2 
 
Key words  peritoneal dialysis bioimpedance   peritoneal protein 
  extracellular fluid  hydration fast transporter  
 
 
short title –  serial changes in peritoneal protein transport  





Faster peritoneal transport status has been associated with adverse outcomes for 
peritoneal dialysis (PD) patients. Peritoneal protein clearance, through large pores, may 
be a surrogate marker of local inflammation. We wished to determine whether 
peritoneal protein transport increased with PD duration or was associated with 
extracellular water (ECW) expansion. 
 
Methods  
We studied the relationships between 4hour Dialysate (D)/Serum (S) protein and ECW 
excess, using multifrequency bioelectrical impedance assessments, in 103 PD patients 
with up to four years of prospectively collected peritoneal equilibrium test (PET) 
results. 
   
Results  
4hr PET D/S total protein and creatinine ratios were stable over time ((K-W test, p = 
0.063 and p = 0.3357 respectively). The initial PET 4hr D/S creatinine and D/S total 
protein correlated with ECW excess (r = 0.33, p = 0.003, and r = 0.27, p = 0.019 
respectively), but thereafter there was no association. CRP and albumin did not 
correlate with 4hr D/S creatinine or total protein. Serial 4hr D/S total protein and 4hr 





At the start of PD therapy, over-hydration (ECW excess) was observed with higher 4hr 
D/S creatinine and 4hr D/S total protein ratios, suggesting initial exposure to PD fluids 
causes faster transport. Thereafter changes in peritoneal creatinine and total protein 
transport mirrored each other suggesting that similar factors lead to changes in both 
small and large pore transport, and there was no sustained increase in larger pore 
transport with therapy time. 
 
Introduction 
The relationships between peritoneal membrane transport characteristics, local 
and systemic inflammation and patient outcomes remain controversial. Data suggesting 
that outcome (including mortality) is worse for faster peritoneal transporters treated 
by continuous ambulatory peritoneal dialysis (CAPD) were reported by the CANUSA 
study group [1]. This was followed by a large meta-analysis which also observed an 
association between faster transport status and adverse outcomes, although the use of 
automated peritoneal dialysis cyclers (APD) appeared to modify this risk [2]. However 
more recent studies have reported no correlation between faster transporter status 
and patient or technique survival in peritoneal dialysis (PD) populations using APD [3,4].  
Peritoneal membrane transport rate has a number of determinants; including 
patient size, as this will affect peritoneal surface area and blood supply. Inflammation, 
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both systemic and locally within the peritoneum, is also likely to increase local blood 
supply, and faster peritoneal transport has been observed with higher levels of both 
plasma and dialysate interleukin-6 (IL-6) [5] In addition genetic polymorphisms 
resulting in greater IL-6 production may also be associated with faster peritoneal 
transport [6]. 
Peritoneal protein clearance depends upon large pore fluid flux, which has been 
reported to increase with inflammation, patient age, co-morbidities and generalised 
vascular disease [7,8]. The importance of peritoneal dialysate protein losses, 
(predominantly albumin) remains unclear. Some groups, including our own, have reported 
an association with increased patient mortality and PD technique failure [9,10]. 
However this remains controversial with other studies reporting no such association 
[11]. These differences between reports may be consequent on different clinical 
practices in terms of prescribing peritoneal dialysis, as peritoneal protein clearance can 
be modified by exchange dwell times with shorter dwell times tending to reduce 
protein losses, particularly for those patients who are slower peritoneal transporters.  
Inflammation can lead to endothelial dysfunction [12], with increased capillary 
permeability and extracellular water (ECW) expansion, although again the latter could 
be modified by the PD prescription [13]. On the other hand, PD patients may have an 
expanded ECW, with a lower serum albumin, but this does not necessarily always imply 
an expanded plasma volume [14,15]. To investigate this further, we wished to explore 
the relationships between small and large pore transporter status and bioimpedance 
derived hydration status, and whether these changed over time, as over-hydration due 
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to increased capillary permeability would link faster transporter status with ECW 
excess, and provide a potential cause for the increased mortality reported with daily 
peritoneal protein losses [9].  
 
Methods 
We compared 4 hour peritoneal dialysate effluent creatinine and total protein 
to corresponding serum samples (S) when PD patients attended for routine outpatient 
peritoneal equilibrium testing (PET) using a standard 22.7 g/l dextrose exchange as 
part of their routine clinical care. Dialysate (D) creatinine was measured using a kinetic 
enzymatic method to prevent glucose interference (P module analyzer, Roche Integra, 
Roche diagnostics, Lewes, UK). Serum and dialysate total protein were measured by a 
modified biuret method (colorimetric assay based on divalent copper reacting in 
alkaline solution with protein peptide bonds to form a characteristic purple-coloured 
biuret complex, measuring increased absorbance at 546 nm), and peritoneal dialysate 
protein using pyrogallol red which complexes with proteins in an acid environment 
containing molybdate ions, and measuring absorbance at 600nm. This method is linear 
up to 2.14 g/L (higher concentration samples were diluted to bring them into range). 
Serum albumin was measured by bromcresol green method (P module analyzer, Roche 
Integra, Roche diagnostics, Lewes, UK  [16]).C-reactive protein (CRP) was measured 
using the same assay as the UK National Amlyoid centre, with values reported down to < 
1 mg/L, and haemoglobin by an automated counter (Sysmex XN900, Sysmex 
Corporation, Kobe, Japan) [17]. Multifrequency bioelectrical impedance assessments 
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(MFBIA) were made using a standard protocol (InBody 720 Body Composition Analysis, 
Biospace, Seoul, South Korea), with the dialysate drained out at the end of the PET 
[18]. Extracellular water volume (ECW) excess or ECW over hydration was estimated 
according to the method recommended by the European Society for Parenteral and 
Enteral Nutrition (ESPN) [19], or by the ratio of ECW/total body water (TBW). 
Data was available from 103 adult PD patients who had been treated with 
peritoneal dialysis for a minimum of 12 months and had up to four years of annual 
peritoneal equilibration tests. Patients with pacemakers and amputees were excluded 
from MFBIA. These were routine tests performed in stable outpatients and not less 
than six weeks after completing a three week course of antibiotics for the treatment 
of any episode of peritonitis. Data was collected between 2003 and 2012, and co-
morbidity assessed using the Stoke-Davies score [20]. 
 
Statistical Analysis 
Results are expressed as mean ± standard deviation, or median and interquartile 
range, or percentage. Students’ t test was used for parametric and the Mann Whitney 
U test for nonparametric data, anova or Kruskal Wallis with appropriate correction for 
multiple analyses where appropriate, and Spearman correlation used for non-parametric 
data. Statistical analysis was performed using Graph Pad Prism (version 4.0, Graph Pad, 
San Diego, CA, USA). Statistical significance was taken at or below the 5% level. 
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Our audit was approved by the Royal Free Hospital Research and Development 
office as we complied with NHS guidelines (UK NHS guidelines for clinical audit and 
service development, available at http://www.hra.nhs.uk/documents/2013/09/defining-
research.pdf, and http://www.gov.uk/government/publications/health-research-ethics-
committees-governancearrangements).  
Individual consent was waived as all laboratory tests and MFBIA had been 
performed as part of the routine clinical care of kidney dialysis patients in keeping with 
the Royal Free Hospital Trust policy and no patient identifiable data was used.  
 
Results 
Data on PET and MFBIA was reviewed from 103 consecutive patients initiating 
peritoneal dialysis who had MFBIA at the time of their initial PET, a median of 2 
months from the start of PD training, median time from PD catheter insertion 2.0 (2.0-
3.0) months. There were 31 female and 72 male patients, and 18 (17.5%) were diabetic. 
The mean age at first PET was 56.2 years (range 19 – 86 years). The major ethnic 
groups were Caucasoid 50%, African-Afro-Caribbean 22%, South Asian 18% and East 
Asian 8%. 24 patients were treated by automated peritoneal dialysis (APD) with no day 
time exchange, 55 APD with a day time exchange and 24 by continuous ambulatory 
peritoneal dialysis (CAPD), with 75 (72.8%) using a 7.5% icodextrin exchange, and 34 
using 22.7 g/l glucose exchanges. No patient at baseline, or on follow-up, used 
peritoneal glucose exchanges greater than 22.7 g/l.  At baseline the mean haemoglobin 
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was 113.8 ±13.7g/l, serum albumin 37.8 ±4.6 g/l, sodium 139.2 ±3.9 mmol/l, glucose 7.2 
±4.8mmol/l, urea 17.7±5.2 mmol/l, creatinine 525 ±219 umol/l, median C reactive protein 
5.9 (4.5-7.6) mg/l. Residual Kt/Vurea was 1.76 (range 0 - 5.49) and litres of urinary 
combined mean creatinine and urea cleared 71.8 (range 0 – 248.4) L/week/1.73m2. The 
mean weekly peritoneal Kt/Vurea was 1.21 (range 0.21 – 2.97); with a mean weekly total 
Kt/Vurea 2.98 (range 1.27 – 6.66). The mean peritoneal creatinine clearance at baseline 
was 35.7 (range 7.4 – 150.7) L/week/1.73m2, giving a mean total creatinine clearance of 
104.7 (range 26.6 – 237.4) L/week/1.73m2. The mean BMI was 25.8 (range 17.4 – 40.3). 
The median Stoke Davies co-morbidity score for our cohort was 1. The ratio of 
extracellular water (ECW) to total body water (TBW) was 0.393 ± 0.012, and mean 
ECW excess 0.72 ± 0.74 litres. 
Separating patients according to the first PET test (table 1), then faster 
transporters had lower serum albumin, and greater PET 4 hour D/S total protein ratio, 
and greater ECW, but there were no differences in serum total protein or CRP, and no 
differences in patient demographics or comorbidities.  
Thereafter serial annual data was available for 101 patients after 12 months, 82 
after two years, 70 after 3 years and 38 after 4 years. At the end of the study twenty 
patients remained treated by peritoneal dialysis (2 APD, 4 CAPD and 14 APD with a day 
time exchange), twenty had died, thirteen had been transferred to HD and fifty 
transplanted. Residual renal function declined over time, with most having a urine 
output of < 100 ml/day by year 3 (median creatinine clearance 0 (0-5.0) ml/min. During 
the study period the incidence of peritonitis within the centre, was calculated on a 
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monthly basis and varied from a maximum of one episode per 19 months to a minimum of 
one episode per 32 months, median one per 26 months.  
For the whole group the mean 4 hour PET D/S creatinine remained stable overall 
over time (Figure 1).  The D/S total protein for the whole group was also stable over 
time (Figure 2). Excluding drop outs, then analysing paired data sets showed that 4 
hour PET D/S creatinine was stable over time. For 4 hour PET D/S total protein, there 
was a significant difference between the initial PET and at four years (Kuskal Walis 
with Dunn’s correction p < 0.05), but not for any other time points.  
There was a statistically significant correlation between the PET 4 hour D/S 
creatinine and the D/S total protein at all-time points (Table 2). We investigated the 
relationships between changes in 4 hour PET D/S creatinine and D/S total protein with 
time in individual patients. There was a positive correlation between the change in 4 
hour PET D/S creatinine and the change in D/S protein from the initial data to the 
three year data (Figure 3). This positive relationship was maintained, at all follow ups, 
even  if the interval chosen was the initial and last data collection for each patient 
regardless of the duration of peritoneal dialysis (r=0.419, p<0.001). 
At the start of peritoneal dialysis therapy, the initial ratio of extra-cellular 
water/total body water (ECW/TBW) and over-hydration correlated with the 4 hour 
PET D/S creatinine (r = 0.331, p = 0.0031, and Figure 4, respectively). Similarly both 
the ECW/TBW ratio and the degree of over-hydration also correlated with the 4 hour 
PET D/S total protein (r = 0.28, p = 0.0137 and r = 0.267, p = 0.0019), respectively. 
However thereafter, at all subsequent time  points there was no statistical correlation 
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between either the ECW/TBW or litres of ECW over hydration and either the 
corresponding 4 hour PET  D/S creatinine or D/S total protein, nor were there any 
significant relationships between changes in D/S creatinine or D/S total protein over 
time and changes in hydration status over the same time period. (supplementary figures 
5-8) 
The 4 hour PET D/S total protein did not correlate significantly with surrogate 
markers of systemic inflammation such as serum albumin or  CRP at any time point, but 
did  correlate with age (r = 0.297, p = 0.0024). The 4 hour PET D/S creatinine also 
correlated weakly with age (r = 0.217, p = 0.0289). The initial 4 hour D/S creatinine 
correlated negatively with the serum albumin (r = -0.358, p = 0.0002); this relationship 
was maintained with time (at one year r = -0.417, p < 0.0001; at two years r = -0.332, p = 
0.0026; at three years r = -0.556, p=< 0.0001; at four years r = -0.347, p = 0.0355). 
There was no statistical correlation between either the 4 hour PET D/S total protein 
or the D/S creatinine and either CRP or the Stoke-Davies co-morbidity score or grade. 
The ratio of ECW/TBW remained stable over time, being 0.389±0.013 after 
12months, 0.392 ±0.010 after 24 months, 0.392±0.009 after 36 months, and finally 
0.392 ±0.128. Similarly ECW excess was estimated as 0.52 ±0.61 L after 12 months, 
0.73 ±0.51 L after 24 months, 0.84 ± 1.72 L after 36months and finally 0.67 ± 0.62 L, 
and there was no association between changes in peritoneal protein transport and ECW 
excess over time. 
As the majority of patients were transplanted on follow-up, we compared 
patient outcomes. As expected transplanted patients were younger compared to those 
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who died (48.5±14.3 vs 65.7±13.5 years, p<0.05), and had less co-morbidity (Davies 
grade 0/1/2: 30/19/1 vs 3/13/4, X2=27.7, p<0.001), and fewer diabetics (20% vs 50%, 
X2=11.3, p=0.01), and had lower ECW/TBW ratio (0.39±0.01 vs 0.40±0.02, p<0.05). 
However there were no differences in PD modality, use of icodextrin. 22.7 g/l glucose 
or physioneal usage, or standard PET test results. The 4 hr PET D/S total protein, and 
the ratio of D/S total protein to creatinine  were higher in those transferred to 
haemodialysis than those who were transplanted (0.021±0.009 vs 0.008±0.006, and 
0.023±0.009 vs 0.011±0.001, p<0.05 respectively), but there were no differences with 
those patients who died. 
38 patients continued on peritoneal dialysis and had serial data for more than 4 
years.  When peritoneal creatinine and protein transporter status (PET results), serum 
total protein and 24 hour peritoneal protein losses at enrolment were compared with 




Previous studies, typically based on CAPD cohorts, have reported an association 
between faster transporter status and both PD technique failure and mortality [1,2], 
whereas other observational studies have linked faster transporter status to patient 
co-morbidity and ECW over hydration [8, 21]. However other reports have not shown 
the same associations between faster transporter status and outcomes [3], or ECW 
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volume overload [22], but instead have noted associations between inflammation as 
assessed by increased serum CRP and reduced serum albumin concentrations and ECW 
excess [23]. As such we looked at the association between the standard 4 hour PET 
D/S creatinine and total protein ratios, as markers of small and large pore fluxes, and 
MFBIA derived volume assessments in a cohort of peritoneal dialysis patients over 
time, to ascertain whether ECW over hydration was driven by increased large pore 
fluxes. 
At the start of peritoneal dialysis we found that there was a significant 
correlation between both the initial 4 hour PET D/S creatinine and the D/S total 
protein and ECW over-hydration, and a negative correlation with serum albumin, 
consistent with the hypothesis that over-hydration may be related to faster peritoneal 
transporter status secondary to generalised or local inflammation [5] and so help to 
explain the association reported between fast transporter status and peritoneal 
dialysis technique failure and worse patient outcomes [1,12]. Our results on total 
protein transport and hydration status support an earlier study which reported an 
initial relationship between peritoneal albumin and creatinine transport [11]. This latter 
study also noted an association between peritoneal albumin transport and increased co-
morbidity, however there were differences between this study and ours both in terms 
of patient co-morbidity and peritoneal membrane testing [11]. Increased  peritoneal 
protein and creatinine transporter status could be secondary to local peritoneal 
inflammation following exposure to hypertonic low pH lactate based peritoneal dialysis 
fluids which was still present at the time of the first PET, and then with time either 
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there was adaptation to the effect of peritoneal dialysates or changes made in the 
peritoneal dialysis prescription adjusted for the membrane properties designed to 
reduce patient over-hydration [13,24]. However there were no differences in 
peritoneal dialysis modality, or usage of 22.7 g/l glucose dialysates or physioneal, 
although more faster transporters used icodextrin. We did not find any association 
with either small pore or large pore transport and CRP or ECW over hydration on 
repeat testing of peritoneal membrane function. However there was a negative 
correlation between the 4 hour D/S creatinine and serum albumin at all-time points, 
whereas there was no such association with 4 hour D/S total protein at any time point. 
As lower serum albumin concentrations are associated with adverse outcomes, 
supporting previous studies [11], this would support a link between faster small solute 
transport and PD technique failure and patient mortality [1,2]. The question arises as to 
why there was no association with ECW as serum albumin concentrations are recognised 
to be affected by hydration status, and residual renal function. However MFBIA 
results were available to the clinicians and as such changes in PD prescription to adapt 
to loss of residual renal function could have abrogated ECW expansion [25], as not all 
peritoneal dialysis patients become volume overloaded when residual renal function is 
lost [26] . In addition, in keeping with the majority of UK laboratories we used the 
bromocresol green method to measure serum albumin, which may be less reliable in 
patients with lower serum albumin levels due to interactions with the plasma globulin 
fraction [27]. This may potentially explain the lack of association between 4 hour D/S 
total protein and serum albumin. 
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In our cohort 4 hour D/S creatinine remained stable, whereas other reports 
have suggested a progressive increase in D/S creatinine with duration of PD therapy 
[28]. Although this increasing D/S transporter status has been linked to previous 
peritonitis episodes [29], and changes in peritoneal membrane predisposing to 
encapsulating peritoneal sclerosis [30], it is now recognised that small pore transporter 
status does not increase in all PD patients over time [31]. Similarly we found that for 
the whole group then over time peritoneal large pore flux, as determined by 4 hour PET 
D/S total protein also remained stable, in keeping with previous reports [8,31], 
suggesting that there was no progressive change in the peritoneal membrane “leakiness” 
to larger molecules during the period of treatment with PD. If anything 4 hour D/S 
protein was lower after 4 years, which may been due to a residual inflammatory effect 
due to the initial exposure to peritoneal dialysis fluids at the time of the first PET 
test. 
At each time point we found a correlation between 4 hour PET small pore and 
large pore transport. Some studies based on albumin measurements have suggested 
that peritoneal surface area may increase with duration of PD therapy, so that there 
could be some divergence between small and large pore transport [8,32]. However in 
our study for individual patients changes in the 4 hour PET D/S creatinine were 
associated with similar changes in the same direction for the D/S total protein. There 
are some major differences between our study and these reports, in that we had a high 
usage of icodextrin, and were much less reliant on hypertonic glucose exchanges, with 
no patients using glucose concentrations in excess of 22.7 g/l glucose dialysates. As 
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such this combination may have resulted in less ECW volume expansion [33] and 
reduced exposure to glucose and glucose degradation products. Secondly we measured 
total protein, whereas previous studies relied on the peritoneal albumin measurements 
[8,32]. Although there may potentially be differences between total protein and 
albumin peritoneal transport, it is more likely that studies which have measured 
peritoneal dialysate effluent albumin as a surrogate of protein transport could well be 
confounded by the bromocresol green method, which is recognised to be less accurate 
at lower albumin concentrations, and is prone to interactions with the globulin protein 
fraction [27].  
The D/S creatinine is determined by the number of small pores, a function of 
capillary surface area. This may be related to local inflammation within the peritoneal 
space. The D/S protein is thought also to be related to inflammation; large pore 
“leakiness” might be determined by either local or systemic inflammation [10]. Our 
observation that D/S protein so closely paralleled the D/S creatinine suggests that the 
same factors are affecting both parameters. One explanation for this could be that 
local mediators affect both the small and large pore permeability in the peritoneum. 
Changes in permeability would be expected to lead to an expansion in ECW, rather than 
expansion in plasma volume [15,34], and as such would lead to reports of both increased 
peritoneal protein and creatinine transport  being linked to PD technique failure and 
patient mortality [1,2,10,32]. However we found no association between peritoneal 
protein transport and ECW excess over time. 
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In any observational longitudinal study there will be the inevitable question of 
whether results can be biased due to a survivor effect, as patients drop out from 
follow up. In the UK where there is an active kidney transplant program, as expected 
younger patients and those with less co-morbidity were more likely to be transplanted. 
On the other hand patients who died did not have faster peritoneal transport for 
protein or creatinine. As such the observation that there was no change in peritoneal 
protein to creatinine transport over time would provide further support for our 
findings. Additionally we did not find differences in enrolment peritoneal transport 
status for creatinine or protein for those patients who remained on peritoneal dialysis 
for more than 4 years and those who did not. The majority of our patients used 7.5% 
icodextrin dialysate and no patient received glucose dialysates of more than 22.7 g/l, 
and although we cannot exclude an effect due to dialysates, we feel that this is 
unlikely, as there were no differences in peritoneal protein transport between the 
different treatment modalities.   
Our data is consistent with that of other groups who have demonstrated a 
stable 4 hour PET D/S albumin and extends the data on relationships between D/S 
total protein and D/S creatinine with time on peritoneal dialysis. In summary, the 
stability of the D/S total protein over time argues against the hypothesis that 
continued exposure to peritoneal dialysates causes progressive increase in peritoneal 
large pore transport. The early association of D/S total protein with over-hydration 
suggests that over-hydration might be a consequence of a local inflammatory state 
when patients were first exposed to peritoneal dialysates; however this effect did not 
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persist over time. The close association with the D/S creatinine suggests that common 
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Figure 1 shows the 4 hour peritoneal dialysis equilibrium test D/S creatinine data at 
yearly intervals. Data presented as median and interquartile range (whiskers indicate 
range).p=0.3 by Kruskal Wallis. 
 
 
Figure 2 shows the 4 hour peritoneal dialysis equilibrium test D/S total protein data at 
yearly intervals. Data presented as median and interquartile range (whiskers indicate 
range).p=0.89 by Kruskal Wallis. 
 
 
Figure 3: Changes in 4 hour peritoneal dialysis equilibrium test D/S creatinine and D/S 




Figure 4: correlation between the initial 4 hour peritoneal dialysis equilibrium test D/S   




Figure 5: change in extracellular water to total body water ratio compared to change in 
dialysate to serum creatinine ratio at 12 months 
Figure 6: change in extracellular water to total body water ratio compared to change in 
dialysate to serum creatinine ratio at 24 months 
Figure 7: change in extracellular water to total body water ratio compared to change in 
dialysate to serum creatinine ratio at 36 months 
Figure 8: change in extracellular water to total body water ratio compared to change in 




Table 1. Patient characteristics and biochemical results at time of 1st PET test. Results 
as number, mean ±SD, or median (interquartile range) or percentage. Davies co-
morbidity grade (Davies grade), C reactive protein (CRP), serum total protein (serum 
TP), dialysate (D) and serum (S), peritoneal equilibration test (PET). Extra cellular 
water(ECW), total body water (TBW). Final patient outcomes. p values Chi square with 
correction for small numbers or by annova testing with post hoc correction vs fast 
transporters. 
 
transporter Slow Slow average Fast average Fast p value 
D/S creatinine < 0.55 0.55-0.64 0.65-0.80 >0.8  
Male 6 7 24 21  
female 12 8 15 10 0.089 
Age year 54±14.4 44.5±18.3* 58.9±17.6 58.9±14.1 <0.05 
Diabetes 4 3 15 12 0.38 
Davies grade 0 9 6 12 11  
Davies grade 1 8 9 24 17 0.749 
CAPD 2 4 6 12  
APD cycler 17 11 29 22 0.131 
icodextrin 9 10 34 25 0.016 
22.7g/L glucose 5 2 15 12 0.281 
physioneal 5 3 5 9 0.356 
Serum albumin 41.2±4.6* 38.1±5.9 37.6±2.9 36.1±5.3 <0.05 
CRP mg/l 2 (1-3) 5.6(2-11) 4 (1-11) 3 (1-10) >0.05 
Serum TP g/L 69.9±4.0 69.1±7.2 67.4±6.0 65.5±7.7 >0.05 





PET ratio 0.015±0.0 0.012±0.005 0.011±0.004* 0.016±0.01 <0.05 
23 
 






%ECW excess 3.69±3.6 1.38±3.0* 5.87+3.8 7.44±5.8 <0.05 
ECW excess L 0.49±0.49 0.17±0.38* 0.92±0.65 1.10±0.95 <0.05 
peritoneal 
dialysis 
3 3 7 7 0.935 
transplanted 11 17 19 13  
haemodialysis 1 3 4 5  




Table 2: Table of correlation analysis between 4 hour peritoneal dialysis equilibrium 
testing  dialysate to peritoneal ratios for creatinine and total protein at 4 baseline, and 
subsequent years 1,2,3,and 4. Number of patients at each time point (n). 
 
Time Point n Spearman’s r P value 
Baseline 103 r = 0.342 p = 0.0004 
Year 1 84 r = 0.4483 p < 0.0001 
Year 2 82 r = 0.4765 p < 0.0001 
Year 3 70 r = 0.5129 p < 0.0001 







Supplemental Table 1: Data from the initial peritoneal dialysis equilibration testing 
(PET) and peritoneal dialysis adequacy assessments from the 38 patients who remained 
on peritoneal dialysis after 4 years (4year survivors) and the other peritoneal dialysis 
patients. PET samples (4 hour), adequacy samples (24 hour), Dialysate (D), Serum (S, 
Data expressed as mean ± SD. p=not significant for all variables. 
 
variable 4 year survivors Other patients 
4 hour D/S creatinine 0.73 ± 0.15 0.72 ± 0.15 
4 hour D/S total protein 0.008 ± 0.003 0.010 ± 0.008 
4 hour D/S total protein/D/S creatinine 0.012 ± 0.005 0.014 ± 0.008 
4 hour D total protein g/L 0.57 ± 0.21 0.68 ± 0.48 
Serum protein g/L 68.2 ± 7.9 67.2 ± 5.8 
24 hour D total protein g  5.46 ± 3.24 5.33 ± 2.35 
Peritoneal protein clearance ml/24 h 82.41 ± 56.1 80.5 ± 39.2 
 
